Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director Declaration

8th Nov 2018 12:43

RNS Number : 8075G
GlaxoSmithKline PLC
08 November 2018
 

 

 

GlaxoSmithKline plc

 

Director Declaration

 

In conformity with Listing Rule 9.6.14, GlaxoSmithKline plc (the 'Company') hereby notifies the market that Dr Jesse Goodman, a Non-Executive Director of the Company, has been appointed as a Director to the Board of Intellia Therapeutics, Inc. with effect from 31 October 2018.

 

 

V A Whyte

Company Secretary

 

8 November 2018

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RDNEAAFPELAPFFF

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77